OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment
OrthoSpineNews
JANUARY 29, 2025
OrthoPreserve’s implant addresses a significant treatment gap that exists due to the poor outcomes of the standard of care for meniscus tears, a partial meniscectomy, which removes the damaged tissue. OrthoPreserve’s proprietary technology has the potential to disrupt the standard of care and displace more invasive treatments.
52 
Let's personalize your content